SE0302232D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
SE0302232D0
SE0302232D0 SE0302232A SE0302232A SE0302232D0 SE 0302232 D0 SE0302232 D0 SE 0302232D0 SE 0302232 A SE0302232 A SE 0302232A SE 0302232 A SE0302232 A SE 0302232A SE 0302232 D0 SE0302232 D0 SE 0302232D0
Authority
SE
Sweden
Prior art keywords
novel compounds
useful
formula
relates
present
Prior art date
Application number
SE0302232A
Other languages
English (en)
Swedish (sv)
Inventor
Roger Bonnert
Rukhsana Rasul
Steve Thom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302232A priority Critical patent/SE0302232D0/xx
Publication of SE0302232D0 publication Critical patent/SE0302232D0/xx
Priority to TW093123728A priority patent/TW200510303A/zh
Priority to DK04768065.7T priority patent/DK1656347T3/da
Priority to DE602004029580T priority patent/DE602004029580D1/de
Priority to SA04250255A priority patent/SA04250255B1/ar
Priority to AT04768065T priority patent/ATE484494T1/de
Priority to MYPI20043328A priority patent/MY143367A/en
Priority to PL04768065T priority patent/PL1656347T3/pl
Priority to JP2006523677A priority patent/JP4709758B2/ja
Priority to US10/568,889 priority patent/US7709521B2/en
Priority to SI200431554T priority patent/SI1656347T1/sl
Priority to EP04768065A priority patent/EP1656347B1/en
Priority to PCT/GB2004/003502 priority patent/WO2005019171A1/en
Priority to PT04768065T priority patent/PT1656347E/pt
Priority to ES04768065T priority patent/ES2352201T3/es
Priority to UY28473A priority patent/UY28473A1/es
Priority to ARP040102959A priority patent/AR045462A1/es
Priority to CY20101101133T priority patent/CY1110977T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0302232A 2003-08-18 2003-08-18 Novel Compounds SE0302232D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds
TW093123728A TW200510303A (en) 2003-08-18 2004-08-06 Novel compounds
ES04768065T ES2352201T3 (es) 2003-08-18 2004-08-16 Derivados de indol sustituidos para composiciones farmacéuticas para tratar enfermedades respiratorias.
JP2006523677A JP4709758B2 (ja) 2003-08-18 2004-08-16 呼吸器系疾患の処置用医薬組成物のための置換インドール誘導体
US10/568,889 US7709521B2 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
SA04250255A SA04250255B1 (ar) 2003-08-18 2004-08-16 مشتقات اندول مستبدلة لعمل تركيبات صيدلانية لعلاج امراض يسببها بروستجلاندين d2
AT04768065T ATE484494T1 (de) 2003-08-18 2004-08-16 Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
MYPI20043328A MY143367A (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
PL04768065T PL1656347T3 (pl) 2003-08-18 2004-08-16 Podstawione pochodne indolu do środków farmaceutycznych do leczenia chorób układu oddechowego
DK04768065.7T DK1656347T3 (da) 2003-08-18 2004-08-16 Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
DE602004029580T DE602004029580D1 (de) 2003-08-18 2004-08-16 Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
SI200431554T SI1656347T1 (sl) 2003-08-18 2004-08-16 Substituirani indolni derivati za farmacevtske sestavke za zdravljenje respiratornih bolezni
EP04768065A EP1656347B1 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases
PCT/GB2004/003502 WO2005019171A1 (en) 2003-08-18 2004-08-16 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases
PT04768065T PT1656347E (pt) 2003-08-18 2004-08-16 Derivados de indole substituídos para composição farmacêutica para tratar doenças respiratórias
UY28473A UY28473A1 (es) 2003-08-18 2004-08-17 Nuevos compuestos
ARP040102959A AR045462A1 (es) 2003-08-18 2004-08-18 DERIVADOS DE INDOLES SUSTITUIDOS eTILES COMO COMPUESTOS FARMACEUTICOS PARA EL TRATAMIENTO DE ENFERMEDADES RESPIRATORIAS
CY20101101133T CY1110977T1 (el) 2003-08-18 2010-12-09 Υποκατεστημενα παραγωγα ινδολης για φαρμακευτικη συνθεση για θεραπεια ασθενειων του αναπνευστικου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds

Publications (1)

Publication Number Publication Date
SE0302232D0 true SE0302232D0 (sv) 2003-08-18

Family

ID=28450248

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302232A SE0302232D0 (sv) 2003-08-18 2003-08-18 Novel Compounds

Country Status (18)

Country Link
US (1) US7709521B2 (el)
EP (1) EP1656347B1 (el)
JP (1) JP4709758B2 (el)
AR (1) AR045462A1 (el)
AT (1) ATE484494T1 (el)
CY (1) CY1110977T1 (el)
DE (1) DE602004029580D1 (el)
DK (1) DK1656347T3 (el)
ES (1) ES2352201T3 (el)
MY (1) MY143367A (el)
PL (1) PL1656347T3 (el)
PT (1) PT1656347E (el)
SA (1) SA04250255B1 (el)
SE (1) SE0302232D0 (el)
SI (1) SI1656347T1 (el)
TW (1) TW200510303A (el)
UY (1) UY28473A1 (el)
WO (1) WO2005019171A1 (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0201635D0 (sv) 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
PT1725553E (pt) 2004-03-11 2008-07-16 Actelion Pharmaceuticals Ltd Derivados de tetra-hidropiridoindole
NZ556657A (en) 2004-12-27 2010-10-29 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB0505048D0 (en) * 2005-03-11 2005-04-20 Oxagen Ltd Compounds with PGD antagonist activity
EP1911759A4 (en) 2005-07-22 2010-07-21 Shionogi & Co AZAINDOL DERIVATIVE ANTAGONISTIC EFFECT ON PGD2 RECEPTOR
EP2397476A3 (en) 2005-07-22 2011-12-28 Shionogi & Co., Ltd. Indole derivative having PGD2 receptor antagonist activity
GB0521275D0 (en) * 2005-10-19 2005-11-30 Argenta Discovery Ltd 3-Aminoindole compounds
CN102558021A (zh) * 2006-05-26 2012-07-11 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
US20150072963A1 (en) * 2006-06-16 2015-03-12 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating hair growth
SI2037967T1 (sl) 2006-06-16 2017-04-26 The Trustees Of The University Of Pennsylvania Antagonisti receptorja za prostaglandin d2 za zdravljenje androgene alopecije
PT2046740E (pt) 2006-07-22 2012-08-28 Oxagen Ltd Compostos com atividade antagonista do crth2
PL2051962T3 (pl) 2006-08-07 2012-03-30 Actelion Pharmaceuticals Ltd Pochodne kwasu (3-amino-1,2,3,4-tetrahydro-9h-karbazol-9-ilo)-octowego
PL2133332T3 (pl) 2007-04-11 2014-02-28 Kissei Pharmaceutical Pochodna aza(indolu) i jej zastosowanie do celów medycznych
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
DK2229358T3 (da) 2007-12-14 2011-07-04 Pulmagen Therapeutics Asthma Ltd Indoler og deres terapeutiske anvendelse
MX2010007833A (es) 2008-01-18 2010-08-11 Oxagen Ltd Compuestos que tienen actividad antagonista de crth2.
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
EP2265581A1 (en) 2008-01-22 2010-12-29 Oxagen Limited Compounds having crth2 antagonist activity
WO2009151910A2 (en) * 2008-05-25 2009-12-17 Wyeth Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
JPWO2010074244A1 (ja) * 2008-12-25 2012-06-21 大正製薬株式会社 イソキノリン誘導体
DK2433124T3 (en) * 2009-05-19 2017-06-19 Vivia Biotech Sl PROCEDURES FOR PROVIDING PERSONALIZED MEDICAL EX VIVO TESTS FOR HEMATOLOGICAL NEOPLASMS
KR101752932B1 (ko) * 2009-07-06 2017-07-03 아스트라제네카 아베 4-(아세틸아미노))-3-［(4-클로로-페닐)티오］-2-메틸-1ｈ-인돌-1-아세트산의 중간체 및 그의 제조 방법
WO2011100607A1 (en) 2010-02-11 2011-08-18 Vanderbilt University Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
TWI562987B (en) 2010-03-22 2016-12-21 Actelion Pharmaceuticals Ltd 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
WO2011162274A1 (ja) 2010-06-23 2011-12-29 大正製薬株式会社 イソキノリン誘導体
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
US9096595B2 (en) 2011-04-14 2015-08-04 Actelion Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators
EP2526945A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. New CRTH2 Antagonists
EP2548876A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists
EP2548863A1 (en) 2011-07-18 2013-01-23 Almirall, S.A. New CRTh2 antagonists.
WO2013088109A1 (en) 2011-12-16 2013-06-20 Oxagen Limited Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
EP2827952B1 (en) 2012-03-21 2021-07-07 The Trustees Of The University Of Pennsylvania Composition for stimulating hair growth
PE20161177A1 (es) 2014-03-17 2016-11-18 Actelion Pharmaceuticals Ltd Derivados del acido acetico azaindol y su uso como moduladores del receptor de prostaglandina d2
MX2016011900A (es) 2014-03-18 2016-12-05 Actelion Pharmaceuticals Ltd Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2.
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
TWI695831B (zh) 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Ｃｒｔｈ２拮抗劑化合物及其用途
CA2993972A1 (en) 2015-07-30 2017-02-02 The Trustees Of The University Of Pennsylvania Single nucleotide polymorphic alleles of human dp-2 gene for detection of susceptibility to hair growth inhibition by pgd2
EA035752B1 (ru) 2015-09-15 2020-08-05 Идорсиа Фармасьютиклз Лтд КРИСТАЛЛИЧЕСКАЯ ФОРМА (S)-2-(8-((5-ХЛОРПИРИМИДИН-2-ИЛ)(МЕТИЛ)-АМИНО)-2-ФТОР-6,7,8,9-ТЕТРАГИДРО-5Н-ПИРИДО[3,2-b]ИНДОЛ-5-ИЛ)УКСУСНОЙ КИСЛОТЫ И СОДЕРЖАЩИЕ ЕЁ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
JPH0615542B2 (ja) 1986-07-22 1994-03-02 吉富製薬株式会社 ピラゾロピリジン化合物
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
WO1993005020A1 (en) 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase
FR2692574B1 (fr) 1992-06-23 1995-06-23 Sanofi Elf Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles.
JPH08507067A (ja) 1993-02-24 1996-07-30 メルク エンド カンパニー インコーポレーテッド Ｈｉｖ逆転写酵素阻害剤
US5486525A (en) 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
US5567711A (en) 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
TW472045B (en) 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
WO1999009007A1 (en) 1997-08-21 1999-02-25 American Home Products Corporation Solid phase synthesis of 2,3-disubstituted indole compounds
ATE239013T1 (de) 1997-12-19 2003-05-15 Lilly Co Eli Hypoglykamische imidazoline derivate
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU5886500A (en) 1999-06-23 2001-01-09 Sepracor, Inc. Indolyl-benzimidazole antibacterials, and methods of use thereof
AU7962200A (en) 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
BR0017038A (pt) 1999-12-24 2003-01-07 Aventis Pharma Ltd Azaindóis
CN1431999A (zh) * 2000-05-31 2003-07-23 阿斯特拉曾尼卡有限公司 具有血管损伤活性的吲哚衍生物
US6878522B2 (en) * 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
TWI317634B (en) 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
CA2473803A1 (en) 2002-02-01 2003-08-07 Robert Greenhouse Substituted indoles as alpha-1 agonists
SE0200356D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200411D0 (sv) 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
JP4484108B2 (ja) 2002-05-16 2010-06-16 塩野義製薬株式会社 Ｐｇｄ２受容体拮抗作用を有する化合物
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
SE0202463D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab Novel compounds
SE0301569D0 (sv) 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
EP1675826A1 (en) 2003-10-14 2006-07-05 Oxagen Limited Compounds having crth2 antagonist activity
SE0303180D0 (sv) 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
GB0500604D0 (en) 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
GB2422831A (en) 2005-02-04 2006-08-09 Oxagen Ltd Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
CN102558021A (zh) 2006-05-26 2012-07-11 阿斯利康(瑞典)有限公司 联芳基或芳基-杂芳基取代的吲哚类化合物
AU2007256564A1 (en) 2006-06-08 2007-12-13 Neurokey A/S Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
AU2007264114A1 (en) 2006-06-28 2008-01-03 Sanofi-Aventis New CXCR2 inhibitors

Also Published As

Publication number Publication date
WO2005019171A1 (en) 2005-03-03
EP1656347A1 (en) 2006-05-17
AR045462A1 (es) 2005-10-26
SI1656347T1 (sl) 2011-01-31
PT1656347E (pt) 2010-12-09
SA04250255B1 (ar) 2009-02-25
JP2007502804A (ja) 2007-02-15
PL1656347T3 (pl) 2011-02-28
CY1110977T1 (el) 2015-06-11
DK1656347T3 (da) 2011-01-10
JP4709758B2 (ja) 2011-06-22
TW200510303A (en) 2005-03-16
ATE484494T1 (de) 2010-10-15
US20060264444A1 (en) 2006-11-23
DE602004029580D1 (de) 2010-11-25
EP1656347B1 (en) 2010-10-13
MY143367A (en) 2011-04-29
US7709521B2 (en) 2010-05-04
ES2352201T3 (es) 2011-02-16
UY28473A1 (es) 2005-03-31

Similar Documents

Publication Publication Date Title
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
SE0201635D0 (sv) Novel compounds
SE0202241D0 (sv) Novel Compounds
TW200510301A (en) Novel compounds
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
SE0301373D0 (sv) Novel compounds
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
CY1109854T1 (el) Παραγωγα αζαδικυκλο(3.1.0)εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
EA200601141A1 (ru) Сульфонамидные производные для лечения заболеваний
MY153719A (en) Prokineticin 1 receptor antagonists
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
TW200728258A (en) Novel compounds
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
GB0519760D0 (en) Novel compounds
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
RS79703A (en) Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
HRP20060420A2 (en) Piperazine derivatives of alkyl oxindoles
EA200602080A1 (ru) Пиперазиновые производные алкилоксиндолов
CY1106649T1 (el) Νεα 1-μεθοξυ-2-φαινυλ-αιθενια χρησιμα δια την παρασκευην 5-καρβοξαλδεϋδο-2,3-διϋδροβενζοξεπινων